SAN DIEGO, Calif-NewBiotics, Inc announced January 8, that H. Michael Shepard, will be the company's president.
Shepard will be responsible for overseeing all aspects of the company's research and development strategies, scientific and corporate collaborations, and related activities.
NewBiotics, a developer of drugs targeted against cancer and infectious disease, is privately held. The company's drugs use a "Trojan horse solution" to fight various diseases.
Shepard, who previously worked for Canji, and Genentech, helped develop the p53gene product for cancer therapy.